Senior insider sale
Chief Scientific Officer at CONTINEUM THERAPEUTICS, INC. — senior position signals high conviction
$275.3K
17.88K shares
LORRAIN DANIEL S. plans to sell 17.88K shares of CONTINEUM THERAPEUTICS, INC. valued at approximately $275.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Units
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/9/2017 | Restricted Stock Units N/A | 914.00 | — |
| Total | 914.00 | ||
Completed
Units to sell
4.17K
Market value
$62.6K
Units to sell
3.82K
Market value
$61.2K
Units to sell
4.30K
Market value
$68.9K
Units to sell
100.00
Market value
$1.6K
Units to sell
400.00
Market value
$6.4K
Units to sell
4.17K
Market value
$62.3K
Planned — Approximate Date
Units to sell
914.00
Market value
$12.3K
Units
17.88K
Value
$275.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 4.17K | $62.6K | — | Completed |
2/25/2026 | 3.82K | $61.2K | — | Completed |
2/24/2026 | 4.30K | $68.9K | — | Completed |
2/19/2026 | 100.00 | $1.6K | — | Completed |
2/11/2026 | 400.00 | $6.4K | — | Completed |
2/3/2026 | 4.17K | $62.3K | — | Completed |
| Planned — Approximate Date | ||||
4/6/2026 | 914.00 | $12.3K | NASDAQ | Planned |
| Total | 17.88K | $275.3K | ||